INTRODUCTION
============

Liver transplantation is a life saving procedure for patients with chronic end-stage liver disease and acute liver failure when there are no available medical and surgical treatment.[@B1]-[@B3] Since Thomas Starzl performed the first liver transplantation in 1963, there have been significant advances in all aspects of organ selection, retrieval, preservation, and implantation techniques. Therefore, the overall 1-year survival for adult and pediatric deceased donor liver transplantation (DDLT) is now expected to be in excess of 85%, with 5- and 10-year survival in excess of 70% and 60%, respectively.[@B4]-[@B7] However, complications of the biliary tract remains a common source of morbidity and mortality. Some authors call it \"Achilles heel of orthotopic liver transplantation.\"[@B8]

Biliary leaks and strictures are the most common biliary complications, but sphincter of Oddi dysfunction, hemobilia, and biliary obstruction from cystic duct mucocele, stones, sludges or casts have also been observed.[@B9]-[@B11] The rate of bile leaks or strictures at the anastomotic site or cut edge of the transected liver, were reported in 15% to 60% of recipients in early, single center reports.[@B12] These high rates of post-transplant biliary complications, may point to an inherently sensitive nature of the biliary epithelium to ischemic damage in comparison to hepatocytes and vascular endothelium.[@B13]

Improving survival of liver transplants, biliary complications also increased in long-term survival patients. These complications not only affect graft survival but also have a major impact on the quality of life for a liver allograft recipient, as they lead to frequent readmission, reoperation, hospital stays, and escalate costs and add to the emotional trauma that patients suffer.

Surgical repair traditionally has been the preferred approach in biliary complication of orthotopic liver transplantation. With advances in therapeutic and diagnostic endoscopy, the nonoperative management of biliary complications has become standard techniques as the preferred diagnostic and therapeutic modalities.

The aim of this review is to overview a present status of endoscopic role in the diagnosis, treatment, outcome, and future directions of biliary stricture related to orthotopic liver transplantation, from the viewpoints on clinical gastroenterologist.

INCIDENCE OF BILIARY STRICTURES
===============================

Studies regarding long-term outcomes after liver transplantation indicate that approximately 5% to 30% of recipients will develop biliary complications after transplantation. The most common biliary complications are bile leaks, anastomotic and intrahepatic strictures, stones, and ampullary dysfunction. Leaks predominate in the early posttransplant period (\<3 months). Stricture formation typically develops gradually over time. Biliary strictures are the most frequent type of late biliary complication (\>3 months) and are typically due to ischemia/reperfusion injury, vascular insufficiency, or fibrotic healing caused by improper technique.[@B14]-[@B17]

Although the strictures can present at any time after the surgery, the mean interval at the time of presentation is 5 to 8 months after orthotopic liver transplantation and the majority present within 1 year,[@B17]-[@B22] but recent studies suggest that their prevalence continue to increase with the time after transplantation.[@B23]

CLASSIFICATION OF BILIARY STRICTURES
====================================

Bile duct strictures after liver transplantation are easily and conveniently classified as anastomotic strictures (AS) and non-anastomotic strictures (NAS). The clinical outcomes of the 2 types are markedly different, rendering their distinction clinically relevant.

NAS account for 10% to 25% of all stricture complications after orthotopic liver transplantation, with an incidence of 1% to 19%; these are often multiple, longer and occur earlier than anastomotic strictures. AS, on the other hand, are isolated, are localized to the site of the anastomosis, and are short in length. Their reported incidence in the modern literature is 4% to 9%.

PATHOGENESIS AND RISK FACTORS
=============================

1. AS
-----

The underlying basis for AS includes ischemia or fibrosis following a suboptimal surgical technique or a bile leak in the postoperative period.[@B21],[@B23],[@B24] Early in the postoperative period, technical issues appear to be the most important: improper surgical techniques, small caliber of the bile ducts, a mismatch in size between the donor and recipient bile ducts, inappropriate suture material, tension at the anastomosis, excessive use of electrocauterization for control of bile duct bleeding, and infection.[@B8]

Later onset anastomotic strictures most likely indicate fibrotic healing arising from ischemia at the end of the donor or recipient bile duct.[@B14]-[@B16],[@B21],[@B23]-[@B25]

According to some series of whole organ orthotopic liver transplantation, they are reported to be more common after hepaticojejunostomy than after direct duct-to-duct anastomosis,[@B9],[@B11],[@B26] as well as following duct-to-duct anastomosis in non-T-tube recipients, as compared to the anastomosis over a T-tube.[@B27]-[@B30] In right lobe living-donor transplants, the incidence of duct to duct anastomotic strictures has been consistently higher, as compared to recipients of whole liver grafts.[@B31]-[@B35] This is considered to be related to the blood supply of the anastomosis and often the presence of multiple and small caliber donor ducts.

2. NAS
------

NAS are heterogeneous entities, and on the basis of the etiology, Moench et al.[@B36] proposed a classification dividing them into NAS secondary to macroangiopathy and NAS secondary to microangiopathy (preservation injury, prolonged cold and warm ischemia times, donation after cardiac death, and prolonged use of vasopressors in the donor) and immunogenicity (chronic rejection, ABO incompatibility, autoimmune hepatitis, and primary sclerosing cholangitis). Less important and inconsistent are the reported associations with hepatitis C and cytomegalovirus.[@B11],[@B37],[@B38]

NAS present earlier than AS, with the mean time to stricture development being 3.3 to 5.9 months.[@B20],[@B37] Verdonk et al.[@B39] further reported that NAS secondary to ischemic causes presented within 1 year of the transplant, whereas the occurrence after 1 year was more often related to immunological causes as the risk factors.

PRESENTATION
============

Patients may be asymptomatic at presentation, with elevations of serum aminotransferases, bilirubin, alkaline phosphatase and/or gamma-glutamyl transferase levels. A high index of suspicion must be maintained, as pain may be absent in the transplant setting because of immunosuppression and hepatic denervation.[@B40]-[@B42]

A recent report of 15 patients highlighted the use of serum bilirubin \>1.5 mg/dL as a better indirect marker of biliary stasis in living donor liver transplantation (LDLT) than alkaline phosphatase, which is overly sensitive.[@B43]

DIAGNOSIS
=========

Initial evaluation should include liver ultrasound (US) with Doppler evaluation of the hepatic vessels. If hepatic artery stenosis or occlusion is suspected on Doppler US, hepatic angiography is usually indicated. Unfortunately, in liver transplant patients, abdominal US may not be sufficiently sensitive (sensitivity of 38% to 66%) to detect biliary obstruction.[@B44]

In addition, the size of the duct has not been found to be a reliable indicator in following up these patients or in accessing the response to the treatment. Furthermore, there is a significant lack of correlation between the ducal dilatation on the ultrasound and the cholangiographic and clinical feature. It is not clear why the donor bile ducts do not respond to distal obstruction by displaying the same degree of proportional dilation as non transplanted livers.[@B43] However, It is possible that the presence of variable degrees of fibrosis subsequent to the injury sustained at the time of the perioperative period results in less pliable ducts.[@B45]

Scintigraphy of the hepatobiliary tract with 99-technetium labeled iminodiacetic acid identifies strictures with 75% sensitivity and 100% specificity but a lack of therapeutic benefit limits its clinical use.[@B46],[@B47]

Magnetic resonance cholangiopancreatography (MRCP), which has a sensitivity and specificity close to 90% in establishing the diagnosis of biliary strictures.[@B48]-[@B50] MRCP is currently considered an optimal noninvasive diagnostic tool for the assessment of biliary complications after orthotopic liver transplantation.[@B8] Once MRCP expertise becomes more widely available, it should have an even more prominent role in limiting the role of invasive cholangiography for therapeutic purposes. The chief disadvantage is the lack of its therapeutic ability. It can be used as the second step after ultrasound in patients for whom the use of diagnostic endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic cholangiography (PTC) carries a higher operational risk. Cholangiography is considered by all to be the gold standard not only in establishing the diagnosis but also in allowing therapeutic intervention in the same setting.[@B51],[@B52] ERCP has the advantage over PTC and is the first modality of choice as it is not only more physiological but also less invasive. PTC is most often reserved for patients in whom ERCP is unsuccessful and in patients with Roux-en-Y hepaticojejunostomy or choledochojejunostomy. However, newer approaches using the variable stiffness colonoscope, double balloon enteroscope, single balloon enteroscope, and spiral overtube have been made it possible to reach this difficult area.[@B19],[@B53]-[@B56] The characteristic ERCP findings in NAS consist of mucosal abnormalities, narrowing, and prestenotic dilatation, whereas the findings in AS include a thin, short, localized, isolated narrowing in the area of the biliary anastomosis ([Fig. 1](#F1){ref-type="fig"}).

MANAGEMENT
==========

Historically, the management of post-orthotopic liver transplantation biliary strictures consisted of surgical reconstruction in the form of Roux-en-Y hepaticojejunostomy. However, the past 2 decades have seen tremendous growth in the evolution of endoscopic techniques that they are now considered the treatment of choice for biliary strictures.[@B57]-[@B60]

Percutaneous therapy, although it has a success rate of 40% to 85% is still considered a second-line option because of the invasive nature of procedure and the associated complications of hemorrhage, bile leaks and significant morbidity.[@B61] Surgical revision is now reserved for patients who have failed the preceding measures, and retransplantation is the final option when all else fails.

1. NAS
------

Management of patients with NAS is difficult, and any generalized treatment recommendations are difficult to make. Accumulation of biliary sludge and casts renders therapy particularly difficult because of rapid stent occlusion. Treatment of NAS did not result in significant long-term improvement of liver chemistries. It does not appear that the poor response of non-anastomotic treatment to treatment varies with etiology.[@B37] Most importantly, NAS resulted in significantly increased graft loss.

NAS are more resistant to endoscopic treatment, the results of endoscopic approaches have been particularly disappointing in the context of NAS in LDLT. The average success rate varies from 25% to 33%,[@B32],[@B62],[@B63] which is way below the 60% success rate seen with NAS in DDLT.

Endoscopic therapy of non-anastomotic strictures typically consists of extraction of the biliary sludge and casts and balloon dilation of all accessible strictures followed by placement of plastic stents with replacement every 3 month.[@B37] However, balloon dilation of all stricture is not feasible and rapid stent clogging is frequently occurred when managing NAS. Therefore, patients with NAS may required early retransplantation, endoscopic therapy appears to play a more prominent role as a bridge to liver retransplantation.[@B14],[@B64]

2. AS
-----

The conventional method of endoscopic treatment consists of identification of the opening of the stricture followed by cannulation by the guidewire, balloon dilatation of the stricture, and subsequent placement of plastic stents.

Balloon dilation alone without stent placement is only successful in approximately 40% of cases.[@B60] However, Balloon dilation with additional stent placement appears to be more successful with a durable outcome in 75% of patients with anastomotic strictures.[@B60],[@B65] The stents are generally replaced by larger stents every 3 month to prevent the complication of clogging, cholangitis, or stone formation.[@B59],[@B60],[@B66] Dual or multiple stents, by providing greater dilatation, have shown better results than single stents.[@B20],[@B60] Placement of not one, but multiple side-by-side plastic stents further increases successful outcomes in 80% to 90% of patients.[@B59],[@B67],[@B68] In some patients, a transient narrowing at a duct to duct connection appear within the first 30 to 60 days after transplantation, due to postoperative edema and inflammation. This type of stricture responds well to balloon dilatation and temporary stent placement.[@B42] Most patients with anastomotic strictures require ongoing ERCP sessions every 3 month with balloon dilation of 6 to 10 mm and multiple stents of 7 Fr to 10 Fr repeated for 12 to 24 months.[@B42],[@B59],[@B68] An increasing number of stents can be used at each session to achieve a maximum diameter. The treatment is usually completed in 1 year with an average of 3 to 4 stent exchange sessions.[@B18],[@B21],[@B59],[@B66],[@B69] [Figs 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} illustrate the cholangiographic appearances of AS before and after endoscopic treatment in living and DDLT.

The overall long-term success rate of endoscopic treatment for AS associated with DDLT is in the range of 70% to 100%.[@B18],[@B20],[@B21],[@B57],[@B59],[@B66],[@B69]-[@B71] However, endoscopic treatment success rates in AS after LDLT appears significantly less than AS for DDLT at 37% to 71% ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}).[@B62],[@B72],[@B73] When AS are treated appropriately, the long-term results in terms of patient and graft survival are equivalent to those for matched controls without AS.[@B18],[@B57],[@B66],[@B74] A protocol of accelerated dilation every 2 week, and a shortened stenting period of an average of 3.6 months, showed some encouraging results with a high 87% success rate.[@B68]

In patients with duct to duct anastomosis, endoscopic management is hence first line, and it appears that while repeat endoscopic treatment is needed, shorter intervals in between treatments may ultimately reduce the time needed for successful long term outcomes. Despite of limited data, there is some experience in temporary placement of covered self-expanding metal stents to reduce the need for repeated stent exchanges but long term results not identified. In the few situations when endoscopic access to the AS is not obtainable, as in Roux-en-Y reconstructions, another option could be considered. A combined approach where access to the biliary tree is obtained via a percutaneous transhepatic route followed by \"rendezvous\" endoscopy.[@B54],[@B75] The use of percutaneous transhepatic drainage achieves success rates of 50% to 75%.[@B76]-[@B79] Surgical revision and biliary reconstruction with the formation of a hepaticojejunostomy is indicated when endoscopic or percutaneous treatment fails.

ENDOSCOPY PROTOCOL
==================

Endoscopic interventions were performed with duodenoscope after overnight fasting. After selective bile duct cannulation, anastomotic stricture could be detected as a dominant narrowing at the anastomotic site, without effective passage of contrast material, as identified by cholangiography. If the guidewire (0.025 or 0.035 inch) pass into the intrahepatic duct proximal to the site of the stricture, endoscopic sphincterotomy or endoscopic papillary balloon dilation was performed to allow placement of stent.

The anastomotic stricture was then dilated by using high pressure pneumatic balloons that ranged in size from 4 to 10 mm for 30 to 60 seconds. The Soehendra biliary dilation catheter or Soehendra stent retriever (Wilson-Cook Medical GI Endoscopy, Winston-Salem, NC, USA) was sometimes used to dilate the stricture site. A 7 to 10 Fr straight or pigtail plastic stent was inserted after balloon dilatation ([Fig. 4](#F4){ref-type="fig"}).

According to the characteristics of the stricture, including its location, severity of tightness, and angulation, we decided the number, size and form of the stents. For example, if an angulation was present near the stricture site and straightening and migration of the stent was anticipated, a double pig-tail stent was regarded as adequate. If the guidewire could not be passed through the stricture site or minimal narrowing at the anastomosis site that did not impede the flow of contrast material, the percutaneous transhepatic approach was used after the nasobiliary tube was placed distal to the stricture site.

After the initial endoscopic session, ERCP was scheduled electively at intervals of 2 to 3 months for evaluation of the stricture and for stent change. ERCP was performed earlier in cases of cholangitis or worsening liver function. At follow-up ERCP, the stents were removed by using the polypectomy snare or rat tooth forceps. A cholangiogram by occluding the distal common bile duct with a distended retrieval balloon (8.5 to 15 mm) showed a patent anastomotic stricture, then treatment discontinued. If not, balloon dilatation and stent placement were repeated at intervals of 2 to 3 months until the stricture were resolved. [Fig. 5](#F5){ref-type="fig"} summarized the schematic diagram of therapeutic approach for post-LDLT with duct to duct biliary stricture.[@B73]

FUTURE DIRECTIONS
=================

Use of new intraductal endoscopy technologies such as the SpyGlass direct visualization system (Boston Scientific, Natick, MA, USA), which allows visualization of the inner wall of the biliary tree and can act as the guidance system for passage of the guidewire through a tight stricture, has shown some early promise in this area.[@B61],[@B80]-[@B82]

New types of balloons and stents will have significant role in improvement of management of biliary stricture. Preliminary evidence shows that peripheral cutting balloons may be more effective in benign biliary stricture not responsive to standard measures.[@B83] Metal stents have been employed in an effort to reduce stricture recurrence and maintain duct patency. Traditional open-mesh metal stents are associated with occlusion, stone formation, and lack of permanency, epithelial hyperplasia.[@B84] These disadvantages of metal stents have traditionally limited their use in benign biliary strictures. The drawbacks of uncovered metal stents have led to the use of covered metal stents, with the potential benefit that these stents can be removed. However, the use of covered metal stents needs further evaluation to determine their therapeutic effectiveness. Self-expanding stents made of bioabsorbable material may offer several advantages compared to the plastic and self-expanding metal stents.[@B85],[@B86] Studies in porcine models show that these stents offer improved patency because of their large diameter, lower biofilm accumulation and reduced incidence of bile duct proliferative changes. Furthermore, patients do not have to undergo additional procedures to remove the stents. Bioabsorbable stents can be impregnated with pharmaceutical compounds, such as antimicrobial and antineoplastic agents. However, these stents remains investigational at the present time.

CONCLUSIONS
===========

The landscape related to biliary complications after liver transplantation has changed rather rapidly in the past 2 decades. The conventional management of these conditions in the past was mainly surgical. However, therapeutic endoscopy plays an important role in the treatment of post-liver transplant anastomotic strictures. At present, the preferred endoscopic approach is repeated aggressive dilation of the stricture and insertion of multiple plastic stents, particularly anastomotic stricture. Percutaneous and surgical modalities are now reserved for patients in whom endoscopic treatment fails and for those with multiple inaccessible intrahepatic strictures or Roux-en-Y anastomoses. With advances of small bowel endoscopy, Roux-en-Y anastomosis site is accessible to endoscopic treatments. Fully covered metal stents or bioabsorbable stents may provide superior results and deserve further investigation. The area of therapeutic endoscopy will continue to evolve and offer opportunities for innovative new techniques in orthotopic liver transplantation patient related to biliary stricture.

![Cholangiogram of an anastomotic stricture and a non-anastomotic stricture. (A) Short localized anastomotic stricture (arrow). (B) A long nonanastomotic stricture extending proximally from the anastomosis site.](gnl-5-133-g001){#F1}

![A case of anastomotic stricture in a living donor liver transplantation. (A) Retrograde cholangiogram showing a biliary stricture at the anastomotic site (arrow). (B) Insertion of two straight plastic stents across the anterior duct. (C) Six-month follow-up cholangiogram showing resolution of the stricture.](gnl-5-133-g002){#F2}

![Case of anastomotic stricture in a deceased donor liver transplantation (DDLT). (A) A biliary stricture is shown in the anastomosis site following the DDLT (arrow). (B) Two straight plastic stents were inserted through an anastomosis stricture. (C) The biliary stricture was resolved after 3 months.](gnl-5-133-g003){#F3}

![Instruments used for biliary dilatation and stenting. (A) Controlled Radial Expansion (CRE) wire-guided balloon dilatation catheter (Boston Scientific Microvasive). (B) The tips of the Soehendra® biliary dilatation catheter and (C) a Soehendra® stent retriever. (D) From left to right, a double pig-tail stent (Solus double pigtail stent), a single pig-tail stent (Zimmon® pancreatic stent) and a straight plastic (Cotton-Leung® Amsterdam style biliary stent) stent (all produced by Wilson-Cook Medical GI endoscopy).](gnl-5-133-g004){#F4}

![Schematic of the therapeutic approach for the treatment of post LDLT biliary stricture.\
LDLT, living donor liver transplantation; ERC, endoscopic retrograde cholangiography; ENBD, endoscopic nasobiliary drainage catheter.](gnl-5-133-g005){#F5}
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